Aims and scope

The American Journal of Cardiovascular Drugs promotes rational therapy and effective patient management within the discipline of cardiology by providing a regular program of independent review articles covering all aspects of the management of cardiovascular disorders, particularly the place in therapy of newer and established agents and procedures. The journal includes:

• Short overviews of contentious or emerging issues (Current Opinions and Leading Articles, respectively).
• Comprehensive narrative reviews on therapeutic approaches to managing cardiovascular disease.
• Systematic reviews that collate empirical evidence to answer a specific research question, using explicit, systematic methods as outlined by the PRISMA statement.
• Therapy in practice reviews covering optimum management of specific conditions.
• Adis Drug Reviews of the properties and place in therapy of both newer and established drugs in cardiovascular medicine.
• Original research articles reporting the results of well-designed clinical studies, such as clinical pharmacodynamic and pharmacokinetic studies, clinical trials, meta-analyses, outcomes research, and pharmacoeconomic studies.